SG Americas Securities’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $162K | Buy |
+20,972
| New | +$153K | ﹤0.01% | 2740 |
|
|
2025
Q4 | – | Sell |
-7,954
| Closed | -$147K | – | 3591 |
|
|
2025
Q3 | $147K | Buy |
+7,954
| New | +$128K | ﹤0.01% | 2907 |
|
|
2025
Q1 | – | Sell |
-11,940
| Closed | -$203K | – | 3464 |
|
|
2024
Q4 | $203K | Buy |
11,940
+3,705
| +45% | +$69.7K | ﹤0.01% | 2141 |
|
|
2024
Q3 | $191K | Buy |
+8,235
| New | +$176K | ﹤0.01% | 2538 |
|
|
2024
Q2 | – | Sell |
-8,758
| Closed | -$296K | – | 2836 |
|
|
2024
Q1 | $296K | Sell |
8,758
-24,520
| -74% | -$869K | ﹤0.01% | 1698 |
|
|
2023
Q4 | $1.05M | Sell |
33,278
-42,567
| -56% | -$1.01M | 0.01% | 997 |
|
|
2023
Q3 | $1.94M | Buy |
+75,845
| New | +$2.34M | 0.02% | 755 |
|
|
2023
Q2 | – | Sell |
-10,086
| Closed | -$242K | – | 2278 |
|
|
2023
Q1 | $242K | Buy |
+10,086
| New | +$181K | ﹤0.01% | 2287 |
|
|
2022
Q3 | – | Sell |
-22,678
| Closed | -$357K | – | 3173 |
|
|
2022
Q2 | $357K | Buy |
+22,678
| New | +$445K | ﹤0.01% | 2248 |
|
|
2022
Q1 | – | Sell |
-5,965
| Closed | -$221K | – | 2945 |
|
|
2021
Q4 | $221K | Sell |
5,965
-8,802
| -60% | -$359K | ﹤0.01% | 2617 |
|
|
2021
Q3 | $706K | Buy |
+14,767
| New | +$662K | ﹤0.01% | 2214 |
|
|
2021
Q2 | – | Sell |
-7,355
| Closed | -$304K | – | 2844 |
|
|
2021
Q1 | $304K | Buy |
+7,355
| New | +$438K | ﹤0.01% | 2364 |
|
|
2020
Q4 | – | Sell |
-17,931
| Closed | -$769K | – | 3324 |
|
|
2020
Q3 | $769K | Buy |
17,931
+10,551
| +143% | +$524K | ﹤0.01% | 1350 |
|
|
2020
Q2 | $345K | Buy |
+7,380
| New | +$254K | ﹤0.01% | 2414 |
|
Other funds holding ARCT
AIM
NAMA
VCM
VPM
